Form 4: Skyward Specialty Insurance Executive Sells Shares After Stock Award Vesting

Sentiment:

SEC Form 4 Filing


A Skyward Specialty Insurance executive, John A. Burkhart III, sold 1,465 shares of common stock after a restricted stock award vested, with the sale executed under a pre-arranged trading plan.

Summary

  • John A. Burkhart III, President of Specialty Lines at Skyward Specialty Insurance Group, Inc., sold 1,465 shares of common stock on January 2, 2025.
  • The sale occurred after a restricted stock award of 5,065 shares, granted on January 1, 2022, fully vested on January 1, 2025.
  • The shares were sold at a weighted average price of $49.04, with individual transactions ranging from $48.97 to $49.12.
  • The sale was conducted under a Rule 10b5-1 trading plan adopted on August 8, 2024.
  • The reported holdings also include 381 shares acquired on May 31, 2024, and 334 shares acquired on December 1, 2024, through the company's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction by an executive, with no indication of positive or negative sentiment. It's a neutral event.

Industry Context

This is a routine transaction for an executive following the vesting of a stock award, and the use of a 10b5-1 plan is a common practice to avoid insider trading concerns.

Comparison to Industry Standards

  • The use of Rule 10b5-1 trading plans is a standard practice among publicly traded companies to allow insiders to sell shares without concerns about insider trading.
  • Many executives at comparable insurance companies such as Progressive, Allstate, and Chubb use similar plans for stock sales after vesting events.
  • The price range of $48.97 to $49.12 is within the typical trading range for Skyward Specialty Insurance stock, indicating no unusual market activity.

Stakeholder Impact

  • The sale of shares by an executive may have a minor impact on the stock price, but the use of a 10b5-1 plan suggests the transaction was planned and not based on any new information.

Key Dates

DateDescription
01/01/2022Date of grant for the restricted stock award of 5,065 shares.
08/08/2024Date the Rule 10b5-1 trading plan was adopted.
05/31/2024Date of acquisition of 381 shares through the Employee Stock Purchase Plan.
12/01/2024Date of acquisition of 334 shares through the Employee Stock Purchase Plan.
01/01/2025Date the restricted stock award fully vested.
01/02/2025Date of the sale of 1,465 shares.
01/06/2025Date of the filing of the Form 4.

Keywords

Skyward Specialty Insurance, stock sale, executive transaction, restricted stock, Rule 10b5-1, insider trading, employee stock purchase plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.